These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2220603)

  • 21. Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.
    Riegger GA; Liebau G; Holzschuh M; Witkowski D; Steilner H; Kochsiek K
    Am J Cardiol; 1984 Feb; 53(4):614-8. PubMed ID: 6320625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recognized molecular mechanisms of heart failure: approaches to treatment.
    Ceconi C; Cargnoni A; Curello S; Ferrari R
    Rev Port Cardiol; 1998 Oct; 17 Suppl 2():II79-91. PubMed ID: 9835784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroendocrine activation in relation to left ventricular function in chronic severe congestive heart failure: a subgroup analysis from the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
    Eriksson SV; Eneroth P; Kjekshus J; Offstad J; Swedberg K
    Clin Cardiol; 1994 Nov; 17(11):603-6. PubMed ID: 7834934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathophysiology of congestive heart failure].
    Luzza F; Bruni F; Rizzo F; Carerj S
    Minerva Cardioangiol; 2002 Jun; 50(3):209-19. PubMed ID: 12107401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Haemodynamic and neurohumoral response in heart failure produced by rapid ventricular pacing.
    Travill CM; Williams TD; Pate P; Song G; Chalmers J; Lightman SL; Sutton R; Noble MI
    Cardiovasc Res; 1992 Aug; 26(8):783-90. PubMed ID: 1451153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine mechanisms in congestive cardiac failure. Renin, aldosterone and atrial natriuretic hormone.
    Laragh JH
    Drugs; 1986; 32 Suppl 5():1-12. PubMed ID: 2952486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Francis GS; Cohn JN; Johnson G; Rector TS; Goldman S; Simon A
    Circulation; 1993 Jun; 87(6 Suppl):VI40-8. PubMed ID: 8500238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroendocrine changes in chronic cardiac failure.
    Nicholls DP; Onuoha GN; McDowell G; Elborn JS; Riley MS; Nugent AM; Steele IC; Shaw C; Buchanan KD
    Basic Res Cardiol; 1996; 91 Suppl 1():13-20. PubMed ID: 8896739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both.
    Yan RT; White M; Yan AT; Yusuf S; Rouleau JL; Maggioni AP; Hall C; Latini R; Afzal R; Floras J; Masson S; McKelvie RS;
    Am J Cardiol; 2005 Sep; 96(5):698-704. PubMed ID: 16125499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurohormonal activation in congestive heart failure and the role of vasopressin.
    Chatterjee K
    Am J Cardiol; 2005 May; 95(9A):8B-13B. PubMed ID: 15847852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB
    Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurohormonal assessment in heart failure: from the sophisticated laboratory to practical indications].
    Dei Cas L; Metra M; Visioli O
    G Ital Cardiol; 1993 Feb; 23(2):193-204. PubMed ID: 8098306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuro-hormonal mechanisms in heart insufficiency--from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; de Faria DB
    Rev Port Cardiol; 1989 Feb; 8(2):129-48. PubMed ID: 2576635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurohumoral mechanisms involved in congestive heart failure.
    Francis GS
    Am J Cardiol; 1985 Jan; 55(2):15A-21A. PubMed ID: 2857062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine changes in acute myocardial infarction.
    McAlpine HM; Cobbe SM
    Am J Med; 1988 Mar; 84(3A):61-6. PubMed ID: 3064600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure.
    Dzau VJ
    Am J Cardiol; 1988 Sep; 62(8):76E-81E. PubMed ID: 2901216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac afferents and neurohormonal activation in congestive heart failure.
    Davila DF; Donis JH; Bellabarba G; Torres A; Casado J; Mazzei de Davila C
    Med Hypotheses; 2000 Feb; 54(2):242-53. PubMed ID: 10790760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine activation in congestive heart failure.
    Forfar JC
    Am J Cardiol; 1991 May; 67(12):3C-5C. PubMed ID: 2021117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of aging on neuroendocrine activation in subjects and patients in the presence and absence of heart failure with left ventricular systolic dysfunction.
    Dutka DP; Olivotto I; Ward S; Oakley CM; Impallomeni M; Cleland JG
    Am J Cardiol; 1996 Jun; 77(14):1197-201. PubMed ID: 8651095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.